Chemed earnings were $259.8M for the trailing 12 months ending Mar 31, 2026, with -11.3% growth year over year. The latest CHE earnings report on Mar 31, 2026 announced Q1 2026 earnings of $66.3M, down 13.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CHE reported annual earnings of $265.2M, with -12.2% growth.
CHE past earnings growth
How has CHE's earnings growth performed historically?
On CHE's earnings call on Invalid Date, Chemed (NYSE: CHE) reported Q1 2026 earnings per share (EPS) of $4.85, up 1.22% year over year. Total CHE earnings for the quarter were $66.30 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.91.
As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $259.78 million, a 15.86% decrease year over year.
What was CHE's earnings growth in the past year?
As of Chemed's earnings date in Invalid Date, Chemed's earnings has grown -11.35% year over year. This is 38.25 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 26.91%. CHE earnings in the past year totalled $259.78 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.